We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

17 hedge funds and large institutions have $8.62M invested in Champions Oncology in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

42% more funds holding

Funds holding: 12 → 17 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.02% less ownership

Funds ownership: 47.79% → 46.77% (-1%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

57% less capital inflows, than outflows

Capital inflows: $341K | Capital outflows: $790K

Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$123K
2
Virtu KCG Holdings
Virtu KCG Holdings
New York
+$62.4K
3
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$52.1K
4
Millennium Management
Millennium Management
New York
+$41.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$29.5K

Top Sellers

Rank Fund Capital Flow
1
PAR Capital Management
PAR Capital Management
Massachusetts
-$768K
2
SM
Sabby Management
Florida
-$15.1K
3
Morgan Stanley
Morgan Stanley
New York
-$6K
4
UBS Group
UBS Group
Switzerland
-$785

CSBR Hedge Fund Activity: Q3 2016 in Review

17 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2016, worth a combined $8.62M — down 25% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CSBR positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $123K. The largest seller was PAR Capital Management, cutting an estimated $768K.

  • 17 institutional investors held Champions Oncology (CSBR) as of Q3 2016, up from 12 in Q2 2016.
  • Funds reported $8.62M of Champions Oncology stock for Q3 2016, down 25% quarter-over-quarter.
  • 6 funds opened new Champions Oncology positions in Q3 2016 and 1 closed out, a net change of +5 holders.
  • The largest Champions Oncology buyer in Q3 2016 was Goldman Sachs, an estimated $123K added.
  • The largest Champions Oncology seller in Q3 2016 was PAR Capital Management, an estimated $768K sold.

Based on aggregated 13F filings for Q3 2016.